The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 158: ASCO GU 2022 PROpel Phase III olaparib and abiraterone in renal cancer
25 minutes
Posted Feb 19, 2022 at 9:16 pm.
0:00
25:56
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Fred Saad describes the results of this trial.
Previous
Episode 156: ASCO GU 2022 1st line olaparib and durvalumab in bladder cancer
Next
Episode 159: ASCO GU 2022 Adjuvant and neoadjuvant therapy in renal cancer
← See all 496 episodes of The Uromigos